Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?

ABSTRACT:

Background

Healthcare payers in the United States are increasingly tying provider payments to quality and value using pay-for-performance policies. Cost-effectiveness analysis quantifies value in healthcare but is not currently used to design or prioritize pay-for-performance strategies or metrics. Acute ischemic stroke care provides a useful application to demonstrate how simulation modeling can be used to determine cost-effective levels of financial incentives used in pay-for-performance policies and associated challenges with this approach.

Methods and results

Our framework requires a simulation model that can estimate quality-adjusted life years and costs resulting from improvements in a quality metric. A monetary level of incentives can then be back-calculated using the

SUBMITTER: Pandya A 

PROVIDER: S-EPMC7375940 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature